期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

阿立哌唑对女性精神分裂症甲状腺激素、泌乳素的影响 被引量：1

下载PDF
导出
摘要 阿立哌唑属喹啉酮衍生物，为新一代非典型抗精神病药，是第一个被称为多巴胺系统稳定剂的药物。为探讨阿立哌唑治疗女性精神分裂症的疗效及安全性，我们进行了临床观察，现报道如下。
作者 黄慧玲 王飞 胡根友
机构地区 永康市第三人民医院
出处 《浙江医学》 CAS 2007年第6期614-615,共2页 Zhejiang Medical Journal
关键词 精神分裂症 阿立哌唑 甲状腺激素 女性 泌乳素 非典型抗精神病药 喹啉酮衍生物 多巴胺系统
分类号 R749.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献6

  • 1黄文武,姜德国.抗精神病新药阿立哌唑[J].上海精神医学,2003,15(5):307-308. 被引量：153
  • 2Kane J M,Carson W H,Saha A R,et al.Efficacyand safety of aripiprazole and haloperidol versus placebo inpatients with schizophrenia and sehizoaffective disorder[J].J Clin Psychiatry,2002,63(9):763-771.
  • 3Marder S R,MeQuade R D,Stock E,et al.Aripiprazole in the treatment of schizophrenia:safety and tolerability in short-term placebocontrolled trims[J].Schizophr Res,2003,61:123-136.
  • 4Yokoi F,Grunder G,Biziere K,et al.Dopamine D2 and D3receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597):a study using positron emission tomography (PET) and[11C] raclopride[J].Neuropsychopharmacology,2002,27(2):248-259.
  • 5Inoue A,Seto M,Sugita S,et al.differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary[J].Brain Res,1998,55:285-292.
  • 6Hirose T,Uwahodo Y,Yamada S,et al.Efficacy and favorable sideeffect profile of aripiprazole determined in rat with apomorphineinduced stereotype,catalepsy and ptosis induction[J].Int J Neuropsychopharm,2000,3:131-136.

二级参考文献15

  • 1[1]Kikuchi T, Tottori K, Uwahodo Y, et al. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl] butyloxy)-3,4-dihydro-2 ( 1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. J Pharmacol Exp Ther, 1995 Jul, 274( 1 ) :329 ～ 336
  • 2[2]Fleishhacker WW. New developments in the pharmacotherapy of schizophrenia. J Neural transm Suppl, 2003, 105 ～ 117
  • 3[3]Oshiro Y, Sato S, Kurahashi N, et al. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[ 4-( 4-phenyl-1-piperazinyl ) butoxy ]-3, 4-dthydro-2 (1H)-quinolinone derivatives. J Med Chem, 1998 Feb, 41 : 658 ～667
  • 4[4]Matsubayashi H, Amano T, Sasa M. Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra. Psychopharmacolgy (Berl), 1999 Sep, 146(2) : 139 ～ 143
  • 5[5]Lawler CP, Prioleau C, Lewis MM, et al. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropschopharmacolgy, 1999 Jun, 20(6) : 612～627
  • 6[6]Inoue A, Seto M, Sugita S, et al. differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat ptiuitary. Brain Res Mol Brain Res, 1998 apr, 55 : 285 ～292
  • 7[7]Shapiro DA, Renock S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.Neuropsychopharmacology, 2003 May
  • 8[8]Jordan S, Koprivica V, Chen R, et al. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT ( 1 A) receptor. Eur J Pharmacol, 2002 Apr 26,441(3) : 137 ～140
  • 9[9]Goodnick P J, Jerry JM. aripiprazole: profile on efficacy and safety.Expert Opin Pharmacother, 2002 Dec, 3(12) : 1773 ～ 1781
  • 10[10]Stahl SM. dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors. J Clin Psychiatry, 2001 Nov, 62 (11 ) : 841 ～ 842

共引文献152

同被引文献7

二级引证文献14

浙江医学
2007年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部